ORGO
Price
$2.89
Change
+$0.07 (+2.48%)
Updated
Sep 27 closing price
38 days until earnings call
VTRS
Price
$11.55
Change
-$0.07 (-0.60%)
Updated
Sep 27 closing price
36 days until earnings call
Ad is loading...

ORGO vs VTRS

Header iconORGO vs VTRS Comparison
Open Charts ORGO vs VTRSBanner chart's image
Organogenesis Holdings
Price$2.89
Change+$0.07 (+2.48%)
Volume$528.18K
CapitalizationN/A
Viatris
Price$11.55
Change-$0.07 (-0.60%)
Volume$6.37M
CapitalizationN/A
View a ticker or compare two or three
ORGO vs VTRS Comparison Chart
Loading...
ORGO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VTRS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ORGO vs. VTRS commentary
Sep 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ORGO is a Hold and VTRS is a Hold.

COMPARISON
Comparison
Sep 29, 2024
Stock price -- (ORGO: $2.73 vs. VTRS: $11.89)
Brand notoriety: ORGO and VTRS are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ORGO: 212% vs. VTRS: 74%
Market capitalization -- ORGO: $374.78M vs. VTRS: $14.18B
ORGO [@Pharmaceuticals: Other] is valued at $374.78M. VTRS’s [@Pharmaceuticals: Other] market capitalization is $14.18B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ORGO’s FA Score shows that 1 FA rating(s) are green whileVTRS’s FA Score has 2 green FA rating(s).

  • ORGO’s FA Score: 1 green, 4 red.
  • VTRS’s FA Score: 2 green, 3 red.
According to our system of comparison, VTRS is a better buy in the long-term than ORGO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ORGO’s TA Score shows that 6 TA indicator(s) are bullish while VTRS’s TA Score has 5 bullish TA indicator(s).

  • ORGO’s TA Score: 6 bullish, 4 bearish.
  • VTRS’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both ORGO and VTRS are a good buy in the short-term.

Price Growth

ORGO (@Pharmaceuticals: Other) experienced а -7.14% price change this week, while VTRS (@Pharmaceuticals: Other) price change was +1.71% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.57%. For the same industry, the average monthly price growth was +1.93%, and the average quarterly price growth was +40.52%.

Reported Earning Dates

ORGO is expected to report earnings on Nov 06, 2024.

VTRS is expected to report earnings on Nov 04, 2024.

Industries' Descriptions

@Pharmaceuticals: Other (+0.57% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTRS($14.2B) has a higher market cap than ORGO($375M). VTRS has higher P/E ratio than ORGO: VTRS (238.80) vs ORGO (70.25). VTRS YTD gains are higher at: 13.265 vs. ORGO (-33.252). VTRS has higher annual earnings (EBITDA): 3.52B vs. ORGO (36M). VTRS has more cash in the bank: 1.18B vs. ORGO (104M). ORGO has less debt than VTRS: ORGO (119M) vs VTRS (18.4B). VTRS has higher revenues than ORGO: VTRS (15.4B) vs ORGO (433M).
ORGOVTRSORGO / VTRS
Capitalization375M14.2B3%
EBITDA36M3.52B1%
Gain YTD-33.25213.265-251%
P/E Ratio70.25238.8029%
Revenue433M15.4B3%
Total Cash104M1.18B9%
Total Debt119M18.4B1%
FUNDAMENTALS RATINGS
ORGO vs VTRS: Fundamental Ratings
ORGO
VTRS
OUTLOOK RATING
1..100
5859
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
15
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8889
PRICE GROWTH RATING
1..100
7853
P/E GROWTH RATING
1..100
131
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTRS's Valuation (15) in the null industry is somewhat better than the same rating for ORGO (78) in the Financial Conglomerates industry. This means that VTRS’s stock grew somewhat faster than ORGO’s over the last 12 months.

VTRS's Profit vs Risk Rating (100) in the null industry is in the same range as ORGO (100) in the Financial Conglomerates industry. This means that VTRS’s stock grew similarly to ORGO’s over the last 12 months.

ORGO's SMR Rating (88) in the Financial Conglomerates industry is in the same range as VTRS (89) in the null industry. This means that ORGO’s stock grew similarly to VTRS’s over the last 12 months.

VTRS's Price Growth Rating (53) in the null industry is in the same range as ORGO (78) in the Financial Conglomerates industry. This means that VTRS’s stock grew similarly to ORGO’s over the last 12 months.

VTRS's P/E Growth Rating (1) in the null industry is in the same range as ORGO (13) in the Financial Conglomerates industry. This means that VTRS’s stock grew similarly to ORGO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ORGOVTRS
RSI
ODDS (%)
Bullish Trend about 1 month ago
0%
Bearish Trend about 1 month ago
0%
Stochastic
ODDS (%)
Bullish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
Momentum
ODDS (%)
Bullish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
MACD
ODDS (%)
Bearish Trend about 1 month ago
0%
Bearish Trend about 1 month ago
0%
TrendWeek
ODDS (%)
Bullish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
TrendMonth
ODDS (%)
Bearish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
Advances
ODDS (%)
Bullish Trend about 1 month ago
0%
Bullish Trend about 2 months ago
72%
Declines
ODDS (%)
Bearish Trend about 2 months ago
0%
Bearish Trend about 2 months ago
64%
BollingerBands
ODDS (%)
Bullish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
Aroon
ODDS (%)
Bullish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
View a ticker or compare two or three
Ad is loading...
ORGO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VTRS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME23.14-0.28
-1.20%
GameStop Corp
TSLA210.60-3.51
-1.64%
Tesla
SPY552.08-11.60
-2.06%
SPDR® S&P 500® ETF Trust
AAPL222.77-6.23
-2.72%
Apple
BTC.X57431.023000-1681.457000
-2.84%
Bitcoin cryptocurrency

ORGO and

Correlation & Price change

A.I.dvisor tells us that ORGO and ESPR have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ORGO and ESPR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORGO
1D Price
Change %
ORGO100%
-5.21%
ESPR - ORGO
28%
Poorly correlated
N/A
ANIP - ORGO
27%
Poorly correlated
-1.13%
AMPH - ORGO
27%
Poorly correlated
-3.61%
AMRX - ORGO
26%
Poorly correlated
-1.96%
VTRS - ORGO
25%
Poorly correlated
-1.57%
More

VTRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTRS has been loosely correlated with PRGO. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if VTRS jumps, then PRGO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTRS
1D Price
Change %
VTRS100%
-1.57%
PRGO - VTRS
43%
Loosely correlated
-1.82%
ALKS - VTRS
34%
Loosely correlated
-1.16%
AMRX - VTRS
33%
Loosely correlated
-1.96%
PAHC - VTRS
27%
Poorly correlated
-5.38%
PETQ - VTRS
27%
Poorly correlated
-0.07%
More